OMC
ATHE

Old Mission Capital’s Alterity Therapeutics ATHE Stock Holding History

Old Mission Capital’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-34,036
Closed -$94.5K – 1286
2023
Q1 		$94.5K Buy
34,036
+30,427
+843% +$104K ﹤0.01% 1273
2022
Q4 		$12.6K Buy
+3,609
New +$13.8K ﹤0.01% 1268
2019
Q3 		– Sell
-1,271
Closed -$17K – 210
2019
Q2 		$17K Buy
+1,271
New +$20.3K ﹤0.01% 257

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $613M AUM 17.83% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Old Mission Capital's ATHE Position: Q2 2023 in Review

Old Mission Capital sold out of Alterity Therapeutics (ATHE) in Q2 2023, closing a stake of 34,036 shares — an estimated $94.5K sold.

Old Mission Capital first reported a position in ATHE in Q2 2019 and held it in 3 quarters. The position peaked at $94.5K in Q1 2023. 7 funds tracked by Wall St. Rank hold ATHE as of Q2 2023.

  • Old Mission Capital reported no remaining Alterity Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Old Mission Capital sold 34,036 Alterity Therapeutics shares in Q2 2023, an estimated $94.5K.
  • Old Mission Capital first reported a position in Alterity Therapeutics in Q2 2019 and held it in 3 quarters.
  • Old Mission Capital's Alterity Therapeutics position peaked at $94.5K in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2023.

Based on Old Mission Capital's 13F filing for Q2 2023, filed 9 Aug 2023.